DRKS00011704招募中不适用
Documentation of specific indications of lipoprotein apheresis -Real World Study - RWS
Apherese Forschungsinstitut0 个研究点目标入组 100 人开始时间: 2017年2月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 90 Years（—）
- 性别
- All
入选标准
- •In the case of the patients examined in the context of this documentation, the indication for lipoprotein apheresis exists. The patients covered in this documentation are routinely treated within the contractual medical care of lipoprotein apheresis. General inclusion / exclusion criteria:
- •The respondent is in a position to give his / her informed consent to study participation after elucidation.
- •Male and female subjects, age = 18 years.
排除标准
- •The following criteria lead to the exclusion / withdrawal of the study for the person concerned:
- •The subject withdraws his consent.
- •Any medical or non-medical reason which, in the opinion of the examiner, requires the completion of the documentation for the subject.
- •The investigation can be terminated at the beginning at any time by the sponsor or the director of the documentation.
研究者
相似试验
已完成
不适用
Clinical study to investigate lipid-modifying effects of a Saskatoon berry extract - a randomized, double-blind, placebo-controlled parallel studyHealthy subjectsDRKS00015503Prairie Berries Europe GmbH50
Unknown
不适用
Characterization of Novel Lipoprotein Properties Associated With an Increased Risk to Develop AtherosclerosisAtherosclerosisNCT04487223Sheba Medical Center60
招募中
不适用
Long-term Characterization of Lipoprotein Apheresis Technologies for Individual Device Adaption (LOLIDA)LipoproteinemiaApheresis Related ComplicationCardiovascular DiseasesNCT05181969Technische Universität Dresden500
已完成
不适用
Clinical study to investigate lipid modifying effects of hydroxytyrosol – a randomized, double-blind, placebo-controlled parallel studyHealthy subjects with slight to moderately elevated LDL-cholesterol level.DRKS00015251Wacker Chemie AG92
已完成
不适用
Role of lipoproteins in cardiovascular disease - the LipidCardio studyI00-I99Diseases of the circulatory systemDRKS00020915Charité - Universitätsmedizin BerlinMedizinische Klinik für Kardiologie1,005